ACOS / AIDS News

rss

For all of your information to stay up to date with AIDS Care Ocean State and the world.

October 13, 2016
Napo Pharmaceuticals Launches Mytesi (crofelemer) as the Only FDA-Approved Treatment for Relief of Noninfectious Diarrhea in HIV+ Patients Launch Includes Copay Savings and Patient Assistance Programs to Ensure Affordable Access to Mytesi™, Formerly Marketed as Fulyzaq®

News & Events